share_log

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.

CVS Health | 4: Statement of changes in beneficial ownership of securities-Director Shulman Douglas H.

西维斯健康 | 4:持股变动声明-董事 Shulman Douglas H.
美股SEC公告 ·  11/25 17:12

Moomoo AI 已提取核心信息

Douglas H. Shulman completed the acquisition of 2,200 shares of CVS Health common stock on 11/21/2024. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Shulman.Following this transaction, Shulman holds a total of 2,200 shares of CVS Health. The transaction was completed on the same day, indicating a swift execution. This acquisition reflects Shulman's direct investment in CVS Health, potentially signaling confidence in the company's future performance.
Douglas H. Shulman completed the acquisition of 2,200 shares of CVS Health common stock on 11/21/2024. The transaction was executed at a price of $57.1 per share, resulting in a total transaction value of approximately $125,620. This acquisition was categorized as a grant, award, or other acquisition, and the shares are held directly by Shulman.Following this transaction, Shulman holds a total of 2,200 shares of CVS Health. The transaction was completed on the same day, indicating a swift execution. This acquisition reflects Shulman's direct investment in CVS Health, potentially signaling confidence in the company's future performance.
道格拉斯·舒尔曼于2024年11月21日完成了对2,200股CVS Health普通股的收购。该交易以每股57.1美元的价格执行,总交易价值约为125,620美元。此次收购被归类为赠款、奖励或其他收购,股份由舒尔曼直接持有。在这笔交易之后,舒尔曼共持有CVS Health的2,200股股份。该交易于当天完成,表明执行速度很快。此次收购反映了舒尔曼对CVS Health的直接投资,这可能表明人们对公司未来业绩充满信心。
道格拉斯·舒尔曼于2024年11月21日完成了对2,200股CVS Health普通股的收购。该交易以每股57.1美元的价格执行,总交易价值约为125,620美元。此次收购被归类为赠款、奖励或其他收购,股份由舒尔曼直接持有。在这笔交易之后,舒尔曼共持有CVS Health的2,200股股份。该交易于当天完成,表明执行速度很快。此次收购反映了舒尔曼对CVS Health的直接投资,这可能表明人们对公司未来业绩充满信心。
声明:本内容仅用作提供资讯及教育之目的,不构成对任何特定投资或投资策略的推荐或认可。 更多信息